Literature DB >> 26045841

Incidence of anticardiolipin antibodies and lupus anticoagulant factor among women experiencing unexplained recurrent abortion and intrauterine fetal death.

Noura Al Jameil1, Poonam Tyagi1, Amal Al Shenefy2.   

Abstract

The aim of this research study was to estimate anticardiolipin (IgG & IgM) antibodies (aCL) and lupus anticoagulant (LA) factor in patients of recurrent unexplained pregnancy loss and intrauterine fetal deaths (IUFD). 82 women were selected for this study by virtue of having more than two consecutive unexplained pregnancy losses in their first trimester and were referred by the department of Obstetrics and Gynecology, King Saud Medical City Hospital, Riyadh, KSA. All patients had gone through a standardized investigation sequence. Lupus anticoagulants and Anticardiolipin antibodies (IgM and IgG) were detected in the serum by the enzyme linked immunosorbent assay method. To check the significance of aCL and LA, two-tailed t-test was done. Non parametric data was calculated either by Chi-Square test or Fischer exact test when relevant. Total 82 females grouped as 52 cases of recurrent (≥2) mainly first and second trimester miscarriage and 30 cases of recurrent (≥2) late intrauterine fetal death. Lupus anticoagulants was observed in twenty one (21) cases (25.6%) while anticardiolipin antibodies IgM and or IgG positive cases were estimated in forty four (44) cases (53.65%). The prevalence of APS in both studied group was thirty five (35) cases (42.68%). Antiphospholipid antibodies are calculated as the most important reason for recurrent abortion. The patients with unexplained recurrent pregnancy loss must be advised to go for a screening test for all this aPL antibodies.

Entities:  

Keywords:  Anticardiolipin antibodies; antiphospholipid antibodies; intrauterine foetal death; lupus anticoagulant; recurrent pregnancy loss; unexplained infertility

Mesh:

Substances:

Year:  2015        PMID: 26045841      PMCID: PMC4440150     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  22 in total

1.  Antiphospholipid antibodies and recurrent abortion.

Authors:  F Parazzini; B Acaia; D Faden; M Lovotti; G Marelli; S Cortelazzo
Journal:  Obstet Gynecol       Date:  1991-06       Impact factor: 7.661

Review 2.  Pregnancy loss and antiphospholipid antibodies.

Authors:  M D Lockshin
Journal:  Lupus       Date:  1998       Impact factor: 2.911

3.  The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level.

Authors:  M Petri; M Rheinschmidt; Q Whiting-O'Keefe; D Hellmann; L Corash
Journal:  Ann Intern Med       Date:  1987-04       Impact factor: 25.391

4.  The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population.

Authors:  C J Lockwood; R Romero; R F Feinberg; L P Clyne; B Coster; J C Hobbins
Journal:  Am J Obstet Gynecol       Date:  1989-08       Impact factor: 8.661

5.  Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome.

Authors:  D W Branch; R Silver; S Pierangeli; I van Leeuwen; E N Harris
Journal:  Obstet Gynecol       Date:  1997-04       Impact factor: 7.661

6.  Should anticardiolipin tests be performed in otherwise healthy pregnant women?

Authors:  E N Harris; J A Spinnato
Journal:  Am J Obstet Gynecol       Date:  1991-11       Impact factor: 8.661

7.  Autoantibodies and pregnancy history in a healthy population.

Authors:  C Ober; T Karrison; L Harlow; S Elias; N Gleicher
Journal:  Am J Obstet Gynecol       Date:  1993-07       Impact factor: 8.661

8.  Antiphospholipid antibodies in early repeated abortions: a case-controlled study.

Authors:  T Barbui; S Cortelazzo; M Galli; F Parazzini; E Radici; E Rossi; G Finazzi
Journal:  Fertil Steril       Date:  1988-10       Impact factor: 7.329

9.  Antibodies to phospholipids and nuclear antigens in patients with repeated abortions.

Authors:  S Cowchock; J B Smith; B Gocial
Journal:  Am J Obstet Gynecol       Date:  1986-11       Impact factor: 8.661

10.  A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies.

Authors:  H J Out; H W Bruinse; G C Christiaens; M van Vliet; P G de Groot; H K Nieuwenhuis; R H Derksen
Journal:  Am J Obstet Gynecol       Date:  1992-07       Impact factor: 8.661

View more
  4 in total

1.  Prevalence and Resolution of Lupus Anticoagulant in Children.

Authors:  Chandra Kallanagowdar; Aman Chauhan; Mora V Puertolas; Rajasekharan Warrier
Journal:  Ochsner J       Date:  2016

Review 2.  Female Unexplained Infertility: A Disease with Imbalanced Adaptive Immunity.

Authors:  Motahareh Ehsani; Mousa Mohammadnia-Afrouzi; Mohammad Mirzakhani; Sedighe Esmaeilzadeh; Mehdi Shahbazi
Journal:  J Hum Reprod Sci       Date:  2019-12-17

3.  Patterns of Recurrent Thrombosis in Primary Antiphospholipid Syndrome-Multicenter, Real-Life Long-Term Follow-Up.

Authors:  Stanley Niznik; Micha J Rapoport; Orly Avnery; Aharon Lubetsky; Soad Haj Yahia; Martin H Ellis; Nancy Agmon-Levin
Journal:  Front Immunol       Date:  2022-04-19       Impact factor: 8.786

4.  Presumed antiphospholipid syndrome and thrombotic thrombocytopenic purpura: An infrequent association.

Authors:  Hallie Hanna Dolin; Mark Dziuba; Scott M Pappada; Thomas John Papadimos
Journal:  Clin Case Rep       Date:  2019-09-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.